Filing metadata

Accession number
0001209191-21-019568
Form type
Form 3
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Mar 10, 2021
Reporting period
Mar 03, 2021
Description
Initial ownership

Explore SEC Filings Hub